Published: Guidance, quality standards and advice

Skip to filtersSkip to results

Skip to results

Keyword or reference number

Keyword or reference number

Last updated date

Last updated date

Type 1 selected

Type

Guidance programme

HealthTech approach

HealthTech approach

Area of interest

Showing 676 to 700 of 2047

TitleReference numberPublishedLast updated
Empagliflozin for treating chronic heart failure with reduced ejection fractionTA773
Lenalidomide for relapsed or refractory mantle cell lymphoma (terminated appraisal)TA774
Pitolisant hydrochloride for treating excessive daytime sleepiness caused by obstructive sleep apnoeaTA776
Prontosan for treating acute and chronic woundsHTG616
3C Patch for treating diabetic foot ulcersHTG615
Endoscopic full thickness removal of gastrointestinal stromal tumours of the stomachHTG612
Intramedullary distraction for lower limb lengtheningHTG613
Endoscopic balloon dilation for subglottic or tracheal stenosisHTG614
Mental wellbeing at workNG212
PredictSURE IBD and IBDX to guide treatment of Crohn's diseaseHTG610
EarlyCDT Lung for assessing risk of lung cancer in solid lung nodulesHTG611
Pembrolizumab for treating relapsed or refractory classical Hodgkin lymphoma after stem cell transplant or at least 2 previous therapiesTA772
Odevixibat for treating progressive familial intrahepatic cholestasisHST17
Pembrolizumab with carboplatin and paclitaxel for untreated metastatic squamous non-small-cell lung cancerTA770
Daratumumab with bortezomib, melphalan and prednisone for untreated multiple myeloma (terminated appraisal)TA771
Stereotactic radiosurgery for trigeminal neuralgiaHTG608
Microwave ablation for primary or metastatic cancer in the lungHTG609
Daratumumab in combination for untreated multiple myeloma when a stem cell transplant is suitableTA763
Fremanezumab for preventing migraineTA764
Venetoclax with azacitidine for untreated acute myeloid leukaemia when intensive chemotherapy is unsuitableTA765
Pembrolizumab for adjuvant treatment of completely resected stage 3 melanomaTA766
Ponesimod for treating relapsing–remitting multiple sclerosisTA767
Upadacitinib for treating active psoriatic arthritis after inadequate response to DMARDsTA768
Sedaconda ACD-S for sedation with volatile anaesthetics in intensive careHTG607
Glaucoma: diagnosis and managementNG81

Results per page

  1. 10
  2. 25
  3. 50
  4. All